Board of Trustees Meeting Ushers in New Chair, New Vice Chair Elected
The ÃÙȦ×ÊÔ´Õ¾ Board of Trustees met today for its committee and full board meetings to discuss university business, as well as elect Shaun Davis as its new vice chair.
The Nose Knows: Study Establishes Airborne Exposure to Microcystins
A study explored the link between human nasal and environmental microcystin concentrations from harmful algal blooms and detected the toxin in the nasal passages of 95 percent of the participants.
ÃÙȦ×ÊÔ´Õ¾Presents 'Only One' Play About Sex Trafficking
FAU's School of Criminology and Criminal Justice, along with the Peace, Justice and Human Rights Initiative, present "Only One".
Oh My Aching Back: Do Yoga, Tai Chi or Qigong Help?
Researchers provide a comprehensive review of the effects of movement-based mind-body interventions on chronic low back pain.
Choosing Common Pain Relievers: It's Complicated
ÃÙȦ×ÊÔ´Õ¾Schmidt College of Medicine researchers examine benefits and risks of nonsteroidal anti-inflammatory drugs to provide guidance to health care providers and their patients in their clinical decision-making.
Researchers Take Body Armor to the Next Level with High Energy Fibers
FAU's College of Engineering and Computer Science received $569,482 from Combating Terrorism Technical Support Office to develop advanced fibers to enhance the performance of military helmets and body armor.
ÃÙȦ×ÊÔ´Õ¾to Host Events in Honor of Black/African American History Month
ÃÙȦ×ÊÔ´Õ¾ will celebrate Black/African American History Month with a series of events throughout the month of February at its Boca Raton, Jupiter and Broward campuses.
ÃÙȦ×ÊÔ´Õ¾Receives Carnegie Foundation Community Engagement Classification
The Carnegie Foundation has announced that ÃÙȦ×ÊÔ´Õ¾ is one of the 119 U.S. colleges and universities to receive the Carnegie Community Engagement Classification for 2020.
Study Shows New Way to Treat Stroke Using an Already FDA-Approved Drug
Researchers from FAU's Schmidt College of Medicine are the first to report on the neuroprotective properties of granulocyte colony-stimulating factor, an already FDA-approved drug.
Genetic Testing in Diverse Young Breast Cancer Patients over a Decade
Researchers examined racial and ethnic differences in genetic testing frequency and results among diverse breast cancer patients diagnosed at age 50 or younger from January 2007 to December 2017.